When considering its associated molecular deregulation with BRAF mutations, the global literature on cancers differentiates the frequent class I BRAFv600 mutants and class II mutations from class III BRAF mutations because of their independence from NF1/RAS deregulation [62]. Here, BRAF is linked to cancer.